Finally, other cytokines, such as TNF-α, IL-1β, and IL-6 tended to increase the aggressiveness of AML, and anti-inflammatory molecules such as TGF-β seem to block AML progression. The gene discussed is IL1B; the disease is acute myeloid leukemia.